{"count": 1, "results": [{"_id": "35012639", "pmid": 35012639, "pmcid": "PMC8751379", "title": "Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer's disease", "journal": "Alzheimers Res Ther", "authors": ["Fang J", "Zhang P", "Wang Q", "Chiang CW", "Zhou Y", "Hou Y", "Xu J", "Chen R", "Zhang B", "Lewis SJ", "Leverenz JB", "Pieper AA", "Li B", "Li L", "Cummings J", "Cheng F"], "date": "2022-01-10T00:00:00Z", "doi": "10.1186/s13195-021-00951-z", "meta_date_publication": "2022 Jan 10", "meta_volume": "14", "meta_issue": "1", "meta_pages": "7", "score": 50244.297, "text_hl": "Through this approach, we identified 103 ARGs validated by various levels of pathobiological evidence in @<m>DISEASE_Alzheimer_Disease</m> @DISEASE_MESH:D000544 @@@AD@@@. Via network-based prediction and population-based validation, we then showed that three drugs (@CHEMICAL_Pioglitazone @CHEMICAL_MESH:D000077205 @@@pioglitazone@@@, @CHEMICAL_Febuxostat @CHEMICAL_MESH:D000069465 @@@febuxostat@@@, and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@) are significantly associated with decreased risk of @<m>DISEASE_Alzheimer_Disease</m> @DISEASE_MESH:D000544 @@@AD@@@ compared with matched control populations. ", "citations": {"NLM": "Fang J, Zhang P, Wang Q, Chiang CW, Zhou Y, Hou Y, Xu J, Chen R, Zhang B, Lewis SJ, Leverenz JB, Pieper AA, Li B, Li L, Cummings J, Cheng F. Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer's disease Alzheimers Res Ther. 2022 Jan 10;14(1):7. PMID: 35012639", "BibTeX": "@article{35012639, title={Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer's disease}, author={Fang J and Zhang P and Wang Q and Chiang CW and Zhou Y and Hou Y and Xu J and Chen R and Zhang B and Lewis SJ and Leverenz JB and Pieper AA and Li B and Li L and Cummings J and Cheng F}, journal={Alzheimers Res Ther}, volume={14}, number={1}, pages={7}}"}}]}